Quality of life in localised malignant melanoma

Annals of Oncology

Volumn 21, Issue 12, 2010, Pages 2428-2435

  Schlesinger Raab, A ^a   Schubert Fritschle, G ^a   Hein, R ^b   Stolz, W ^c   Volkenandt, M ^a   Holzel D ^a   Engel, J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Klinikum Schwabing   (Germany)

Author keywords

Cancer registry; Communication; Local disease; Melanoma; Population based; Quality of life

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CANCER LOCALIZATION; CANCER REGISTRY; COHORT ANALYSIS; COMORBIDITY; CONSTIPATION; CONTROLLED STUDY; COPING BEHAVIOR; DIARRHEA; DISEASE FREE SURVIVAL; EMOTION; FEMALE; HUMAN; INSOMNIA; INTERPERSONAL COMMUNICATION; LIFESTYLE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MELANOMA; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SEX DIFFERENCE; SEXUAL FUNCTION; SOCIAL STATUS; SOCIAL SUPPORT;

ADULT; AGED; DISEASE PROGRESSION; EMOTIONS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; QUALITY OF LIFE; QUESTIONNAIRES; SEXUAL BEHAVIOR; SKIN NEOPLASMS; TUMOR BURDEN;

EID: 78149397306     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq255     Document Type: Article

References (30)

1. Ries L, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute 2008; based on November 2007 SEER data submission. http://seer.cancer.gov/csr/1975_2005/.
2. Robert-Koch-Institut, GEKID. Gesundheitsberichterstattung des Bundes. Krebs in Deutschland. 2003-2004. Häufigkeiten und Trends. 6th edition. Berlin, Germany, 2008.
3. Tumorregister München. Tumorspezifische Auswertungen. Munich, Germany 2009. http://tumorregister-muenchen.de/facts/specific_analyses.php.
4. Coates A, Thomson D, McLeod GR, et al. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer 1993; 29A: 1731-1734.
5. Beusterien KM, Ackerman SJ, Plante K, et al. The health-related quality-of-life impact of histamine dihydrochloride plus interleukin-2 compared withinterleukin-2 alone in patients with metastatic melanoma. Support Care Cancer 2003; 11: 304-312.
6. Trask PC, Paterson AG, Esper P, et al. Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferon. Psychooncology 2004; 13: 526-536.
7. Dixon S, Walters SJ, Turner L, Hancock BW. Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: results from randomised trial. Br J Cancer 2006; 94: 492-498.
8. Cole BF, Gelber RD, Kirkwood JM, et al. Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study. J Clin Oncol 1996; 14: 2666-2673.
9. Kilbridge KL, Cole BF, Kirkwood JM, et al. Quality-of-life-adjusted survival analysis of high-dose adjuvant interferon alpha-2b for high-risk melanoma patients using intergroup clinical trial data. J Clin Oncol 2002; 20: 1311-1318.
10. Chiarion-Sileni V, Del Bianco P, De Salvo GL, et al. Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients. Eur J Cancer 2003; 39: 1577-1585.
11. Kiebert GM, Jonas DL, Middleton MR. Health-related quality of life in patients with advanced metastatic melanoma: results of a randomized phase III study comparing temozolomide with dacarbazine. Cancer Invest 2003; 21: 821-829.
12. Noorda EM, van Kreij RH, Vrouenraets BC, et al. The health-related quality of life of long-term survivors of melanoma treated with isolated limb perfusion. Eur J Surg Oncol 2007; 33: 776-782.
13. Cornish D, Holterhues C, van de Poll-Franse LV, et al. A systematic review of health-related quality of life in cutaneous melanoma. Ann Oncol 2009; 20 (Suppl 6): vi51-vi58.
14. Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer 2009; 45: 747-755.
15. Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods. Part II: Completeness. Eur J Cancer 2009; 45: 756-764.
16. Groenvold M, Klee MC, Sprangers MA, Aaronson NK. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 1997; 50: 441-450.
17. King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996; 5: 555-567.
18. Kerr J, Engel J, Schlesinger-Raab A, et al. Doctor-patient communication: results of a four-year prospective study in rectal cancer patients. Dis Colon Rectum 2003; 46: 1038-1046.
19. Kerr J, Engel J, Schlesinger-Raab A, et al. Communication, quality of life and age: results of a 5-year prospective study in breast cancer patients. Ann Oncol 2003; 14: 421-427.
20. Greer S, Watson M. Mental adjustment to cancer: its measurement and prognostic importance. Cancer Surv 1987; 6: 439-453.
21. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570-579.
22. Fayers P, Aaronson N, Bjordal K, et al. EORTC QLQ-C30 Scoring Manual. Brussels, Belgium: EORTC 1995.
23. Curran D, Aaronson N, Standaert B, et al. Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study. Eur J Cancer 2000; 36: 834-844.
24. Maisey NR, Norman A, Watson M, et al. Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer 2002; 38: 1351-1357. 25
25. Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001; 37: 1345-1351.
26. Michelson H, Bolund C, Nilsson B, Brandberg Y. Health-related quality of life measured by the EORTC QLQ-C30-reference values from a large sample of Swedish population. Acta Oncol 2000; 39: 477-484.
27. Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S. Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ-C30 (+ 3). J Clin Oncol 1998; 16: 1188-1196.
28. Lehto US, Ojanen M, Vakeva A, et al. Noncancer life stresses in newly diagnosed cancer. Support Care Cancer 2008; 2: 2.
29. Hagedoorn M, Sanderman R, Bolks HN, et al. Distress in couples coping with cancer: a meta-analysis and critical review of role and gender effects. Psychol Bull 2008; 134: 1-30.
30. Dirksen SR. Search for meaning in long-term cancer survivors. J Adv Nurs 1995; 21: 628-633.